Objectives:

As a result of this educational regularly scheduled series, learners as members of the healthcare team will be able to:

  1. Define pharmacogenomics, pharmacogenetics and precision medicine.
  2. Identify resources teams can use to guide pharmacogenetic testing and interpretation in interprofessional practice.
  3. Describe how pharmacogenetic testing can inform decisions around drug selection, dosing and monitoring of psychotropic medications.
  4. Summarize the benefits and challenges pharmacogenetic testing presents for patients and interprofessional teams.

Evaluation

Click here to complete today’s evaluation: https://ce.icep.wisc.edu/app-grand-rounds-20-22-short-eval-15069

Session date: 
Thursday, November 19, 2020 - 12:00pm to 1:00pm
Location: 
Live Stream Only
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
    • 1.00 ANCC Pharmacotherapy Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Casey Gallimore, PharmD, MS